tiprankstipranks
Teva Pharmaceutical (TEVA)
NYSE:TEVA
US Market
TEVA
Teva Pharmaceutical
RESEARCH TOOLSreports
Want to see TEVA full AI Analyst Report?

Teva Pharmaceutical (TEVA) Income Statement

7,707 Followers

Teva Pharmaceutical Income Statement

Last quarter (Q1 2026), Teva Pharmaceutical's total revenue was $3.98B, an increase of 2.31% from the same quarter last year. In Q1, Teva Pharmaceutical's net income was $369.00M. See Teva Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 17.26B$ 16.54B$ 15.85B$ 14.93B$ 15.88B
Gross Profit
$ 8.94B$ 8.06B$ 7.64B$ 6.97B$ 7.59B
Operating Expenses
$ 6.78B$ 8.37B$ 7.21B$ 9.17B$ 5.88B
Depreciation and Amortization
$ 1.00B$ 1.06B$ 1.15B$ 1.31B$ 1.33B
EBITDA
$ 3.14B$ 4.43B$ 1.56B$ -925.00M$ 4.41B
Operating Income
$ 2.16B$ -303.00M$ 433.00M$ -2.20B$ 1.72B
Other Income/Expenses
$ -919.00M$ -980.00M$ -1.05B$ -945.00M$ -1.05B
Pretax Income
$ 1.24B$ -1.28B$ -622.00M$ -3.14B$ 667.00M
Net Income
$ 1.41B$ -1.64B$ -559.00M$ -2.45B$ 417.00M
Per Share Metrics
Basic EPS
$ 1.23$ -1.45$ -0.50$ -2.20$ 0.38
Diluted EPS
$ 1.20$ -1.45$ -0.50$ -2.20$ 0.38
Weighted Average Shares Outstanding
 1.15B 1.13B 1.12B 1.11B 1.10B
Weighted Average Shares Outstanding (Diluted)
 1.17B 1.13B 1.12B 1.11B 1.11B
Currency in USD

Teva Pharmaceutical Earnings and Revenue History